MRL Ventures Fund

Corporate VC

MRL Ventures Fund (MRLV), Merck's corporate venture arm, invests globally in early-stage preclinical therapeutics companies to transform patient care.

Cambridge, United States · 8+ investments · 7 portfolio companies

Seed
Early Stage
Biotech
Healthcare
Headquarters
Cambridge, United States
Founded
2015
Website
mrlv.com
AUM
$500.0M
Portfolio Companies
7
Total Investments
8
Last Investment
Oct 2024
Geographic Focus
Global

Investment Thesis

Backs first-in-class therapeutics innovation across modalities, providing up to $25M capital, board roles, and Merck R&D expertise from concept to clinic.

MRL Ventures Fund is a Corporate VC firm based in Cambridge, United States. It has made 8 investments in Biotech and Healthcare, including Insamo, Alector and Tallac Therapeutics.

Portfolio7

Co-investors24

Sign up to view co-investors

24 co-investors across 28 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×21 · Hedge Fund ×2 · Other ×1 · 29 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

MRL Ventures Fund on Indexed.vc
<a href="https://indexed.vc/investors/mrl-ventures-fund"><img src="https://indexed.vc/api/badge/investor/mrl-ventures-fund" alt="MRL Ventures Fund on Indexed.vc" width="260" height="76" /></a>